Evidence map›Paper›PMID 35702276›Full record

ArticleSkin appendage disorders2022

Patients with Hidradenitis Suppurativa Suffer from Low Health-Related Quality of Life as Measured by the Generic 15D Instrument.

Mirkka J Hirvonen, Rafael Pasternack, Tiina Lipitsä, Armi Vihervaara, Rauno Harvima, Martta Ranta, Harri Sintonen, Laura Huilaja

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Skin appendage disorders, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Comparing EQ-5D-5L, PROPr, SF-6D and TTO utilities in patients with chronic skin diseases.The European journal of health economics : HEPAC : health economics in prevention and care · 2025
    Article
  2. Article
  3. Evaluation of Outcomes Following Surgical Treatment of Hidradenitis Suppurativa.Journal of burn care & research : official publication of the American Burn Association · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 1 country.

Mirkka J HirvonenAbbVie Oy, Espoo, Finland.
Rafael PasternackDepartment of Dermatology, Tampere University Hospital and Tampere University, Tampere, Finland.
Tiina LipitsäDepartment of Dermatology, Kuopio University Hospital and University of Eastern Finland, Kuopio, Finland.
Armi VihervaaraDepartment of Dermatology, Turku University Hospital, Turku, Finland.
Rauno HarvimaDepartment of Dermatology, Kuopio University Hospital and University of Eastern Finland, Kuopio, Finland.
Martta RantaAbbVie Oy, Espoo, Finland.
Harri SintonenDepartment of Public Health, University of Helsinki, Helsinki, Finland.
Laura HuilajaDepartment of Dermatology and Medical Research Center Oulu, Oulu University Hospital, PEDEGO Research Unit, University of Oulu, Oulu, Finland.
ABB (Finland) · FIKuopio University Hospital · FIOulu University Hospital · FITampere University · FITurku University Hospital · FIUniversity of Eastern Finland · FIUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease associated with various comorbidities and diminished quality of life (QoL). Among dermatological conditions, HS is reported to most severely diminish QoL. This study aimed to analyse the health-related QoL (HRQoL) of patients with HS in more detail by using generic to disease-specific HRQoL questionnaires. Correlations between the HRQoL measures and HS disease severity measures were assessed. Methods: We analysed the HRQoL and clinical severity of patients with HS ( Results: The mean 15D score of HS patients was low and comparable with that of patients with cancers. No correlation was found between HS severity measures and 15D score, indicating that even mild HS has a high impact on HRQoL. Conclusions: Our findings strengthen the understanding about HS as a debilitating disease and even compared with non-dermatological conditions and highlight the need of comprehensive care of patients with HS.

Indexed as

15DAcne inversaHidradenitis suppurativaInternational Hidradenitis Suppurativa Severity Score SystemQuality of life

Identifiers

PMID35702276
PMCPMC9149471
OpenAlexW4200088824

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.